Trial Site Detail
Drug: |
Imatinib + Doxorubicin |
|||
|---|---|---|---|---|
Trial: |
Phase I-II clinical trial with Imatinib Mesylate and low doses of Adriamycin in patients with gastrointestinal stromal tumours (GIST) refractory to Imatinib Mesylate. |
|||
| Conditions: | Gastrointestinal Stromal Tumor | |||
Trial Status: |
Completed |
|||
Site name unknown, Barcelona 08036 |
Principal Investigator: |
Joan Maurel |
|---|---|
Contact: |
93-2275402 jmaurel@clinic.ub.es |
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
Site name unknown, Barcelona 08036 Website: |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.